Terumo clarification
This article was originally published in The Gray Sheet
Executive Summary
Terumo VP-Marketing John Rooney will be tasked with growing the marketing and in-house sales support up to 19 people. The firm is growing its external sales reps from 13 to 55 for a combined sales and marketing staff of 74 reps in preparation for going solo after its distribution deal with Boston Scientific ends in March...
You may also be interested in...
New Terumo microcatheter system
Terumo Medical has launched a new coaxial microcatheter system that combines its Progreat microcatheter with its Glidewire GT. The Progreat system - designed to increase procedure efficiency and reduce the risks of procedural problems, such as kinking, according to the company - will be distributed in the U.S. by Boston Scientific until the firms' distribution agreement ends April 1, 2006. Terumo has been building its external sales team in anticipation of that date (1"The Gray Sheet" Feb. 6, 2006, In Brief)...
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.